Teva Pharmaceutical Industries (TEVA) Operating Margin: 2009-2025
Historic Operating Margin for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to 19.69%.
- Teva Pharmaceutical Industries' Operating Margin rose 2086.00% to 19.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.89%, marking a year-over-year increase of 802.00%. This contributed to the annual value of -1.83% for FY2024, which is 456.00% down from last year.
- Teva Pharmaceutical Industries' Operating Margin amounted to 19.69% in Q3 2025, which was up 80.69% from 10.90% recorded in Q2 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Operating Margin peaked at 19.69% during Q3 2025, and registered a low of -25.54% during Q2 2022.
- Over the past 3 years, Teva Pharmaceutical Industries' median Operating Margin value was -0.12% (recorded in 2024), while the average stood at 4.08%.
- In the last 5 years, Teva Pharmaceutical Industries' Operating Margin soared by 12,518bps in 2021 and then crashed by 4,043bps in 2022.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Operating Margin stood at 1.90% in 2021, then crashed by 2,610bps to -24.20% in 2022, then surged by 4,116bps to 16.96% in 2023, then tumbled by 1,765bps to -0.69% in 2024, then soared by 2,086bps to 19.69% in 2025.
- Its Operating Margin was 19.69% in Q3 2025, compared to 10.90% in Q2 2025 and 13.34% in Q1 2025.